Literature DB >> 26754190

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Linda Vignozzi1, Mauro Gacci2, Mario Maggi1.   

Abstract

Epidemiological studies have shown that age is the principal unmodifiable risk factor of lower urinary tract symptoms (LUTS). Until the past decade, the process of lower urinary tract ageing was, therefore, considered unmodifiable - as ageing per se. However, the traditional dogma that BPH-related LUTS (BPH-LUTS) is an immutable consequence of old age is no longer acceptable. Results from multiple preclinical and clinical studies indicate that several modifiable, age-related metabolic aberrations (metabolic syndrome, obesity, dyslipidaemia, diabetes) are important determinants in both the development and the progression of BPH-LUTS. Metabolic syndrome and its related comorbidities, such as sex steroid alterations and low-grade inflammation, have been related to BPH-LUTS development and progression. With the correct treatment and recommended lifestyle changes, many individuals with metabolic syndrome might be able to prevent or delay the onset of metabolic-syndrome-related complications; however, whether promoting healthier lifestyles can really alter a man's propensity to develop BPH-LUTS remains to be clarified.

Entities:  

Mesh:

Year:  2016        PMID: 26754190     DOI: 10.1038/nrurol.2015.301

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  155 in total

1.  Body mass index and risk of BPH: a meta-analysis.

Authors:  S Wang; Q Mao; Y Lin; J Wu; X Wang; X Zheng; L Xie
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-12-20       Impact factor: 5.554

2.  Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.

Authors:  James P Burke; Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Rosebud O Roberts; Cynthia J Girman; Michael M Lieber; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2006-04-12       Impact factor: 4.897

3.  Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey.

Authors:  Yong Gao; Mengjie Wang; Haiying Zhang; Aihua Tan; Xiaobo Yang; Xue Qin; Yanling Hu; Youjie Zhang; Ming Liao; Zengnan Mo
Journal:  Urology       Date:  2011-09-15       Impact factor: 2.649

Review 4.  The gut-adipose-liver axis in the metabolic syndrome.

Authors:  Daniel Konrad; Stephan Wueest
Journal:  Physiology (Bethesda)       Date:  2014-09

5.  Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.

Authors:  Mohammad-Ali Haghsheno; Dan Mellström; Ralph Peeker; Jan Hammarsten; Mattias Lorentzon; Valter Sundh; Magnus Karlsson; Claes Ohlsson; Jan-Erik Damber
Journal:  Scand J Urol       Date:  2014-09-25       Impact factor: 1.612

6.  Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study.

Authors:  J Kellogg Parsons; Karen Messer; Martha White; Elizabeth Barrett-Connor; Douglas C Bauer; Lynn M Marshall
Journal:  Eur Urol       Date:  2011-07-23       Impact factor: 20.096

7.  Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample.

Authors:  Nancy N Maserejian; Shan Chen; Gretchen R Chiu; Andre B Araujo; Varant Kupelian; Susan A Hall; John B McKinlay
Journal:  J Urol       Date:  2013-07-10       Impact factor: 7.450

8.  Physical activity and benign prostatic hyperplasia.

Authors:  E A Platz; I Kawachi; E B Rimm; G A Colditz; M J Stampfer; W C Willett; E Giovannucci
Journal:  Arch Intern Med       Date:  1998-11-23

9.  Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey.

Authors:  Ali E Zumrutbas; Ali I Bozkurt; Erdogan Tas; Cenk I Acar; Okan Alkis; Kazim Coban; Bulent Cetinel; Zafer Aybek
Journal:  Int J Urol       Date:  2014-06-15       Impact factor: 3.369

Review 10.  Diabetes: Advances in Diagnosis and Treatment.

Authors:  David M Nathan
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

View more
  40 in total

Review 1.  The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery.

Authors:  Mauro Gacci; Arcangelo Sebastianelli; Matteo Salvi; Cosimo De Nunzio; Andrea Tubaro; Stavros Gravas; Ignacio Moncada; Sergio Serni; Mario Maggi; Linda Vignozzi
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

2.  Benign prostatic hyperplasia surgical scoring (BPHSS): an novel scoring system for the perioperative outcomes of holmium laser enucleation of the prostate.

Authors:  Huan Xu; Zhikang Cai; Yanbo Chen; Meng Gu; Qi Chen; Zhong Wang
Journal:  Lasers Med Sci       Date:  2018-01-08       Impact factor: 3.161

Review 3.  Mesenchymal stem cells and the embryonic reawakening theory of BPH.

Authors:  W Nathaniel Brennen; John T Isaacs
Journal:  Nat Rev Urol       Date:  2018-11       Impact factor: 14.432

Review 4.  The Complex Relationship Between Lower Urinary Tract Symptoms and Sexual Health.

Authors:  Hanson Zhao; Howard H Kim
Journal:  Curr Urol Rep       Date:  2019-08-29       Impact factor: 3.092

Review 5.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

6.  Toll-like receptor 9 regulates metabolic profile and contributes to obesity-induced benign prostatic hyperplasia in mice.

Authors:  Fabiano B Calmasini; Cameron G McCarthy; Camilla F Wenceslau; Fernanda B M Priviero; Edson Antunes; R Clinton Webb
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

Review 7.  Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base.

Authors:  Mauro Gacci; Arcangelo Sebastianelli; Pietro Spatafora; Giovanni Corona; Sergio Serni; Dirk De Ridder; Stavros Gravas; Paul Abrams
Journal:  Ther Adv Urol       Date:  2017-12-07

8.  Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.

Authors:  Congyun Xu; Yan Xu; Zhou Shen; Hangcheng Zhou; Jun Xiao; Tao Huang
Journal:  Int Urol Nephrol       Date:  2018-02-19       Impact factor: 2.370

9.  Urological complications of obesity and diabetes in males and females of three mouse models: temporal manifestations.

Authors:  Alexandra K Kim; Christine Hamadani; Mark L Zeidel; Warren G Hill
Journal:  Am J Physiol Renal Physiol       Date:  2019-11-04

Review 10.  Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?

Authors:  Granville L Lloyd; Jeffrey M Marks; William A Ricke
Journal:  Curr Urol Rep       Date:  2019-08-03       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.